- Determining the Dose of Azathioprine Based on the Lower Limit of Leukocyte Count in Patients with Crohn's Disease
-
Seo GS
- KMID: 1775743
- Korean J Gastroenterol.
- 2013 Aug;62(2):83-84.
- doi: 10.4166/kjg.2013.62.2.83
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Pleomorphic Liposarcoma in a Patient with Crohn's Disease Taking Azathioprine
-
Ahn SM, Suh SO, Oh YM, Yun CY, Sim HH, Park CA, Song CM, Bae JY
- KMID: 1792745
- Korean J Gastroenterol.
- 2013 Oct;62(4):248-252.
- doi: 10.4166/kjg.2013.62.4.248
Azathioprine is frequently used for the treatment of inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis. Lymphomas, squamous cell carcinomas, and undifferentiated pleomorphic sarcomas have been reported... -
- CITED
-
- Close
- SHARE
-
- Close
- Successful treatment of enteropathy associated with common variable immunodeficiency
-
Choi SW, Seo KW, Oh JS, Lee JS, Cha HJ
- KMID: 1792046
- Korean J Intern Med.
- 2014 Mar;29(2):256-258.
- doi: 10.3904/kjim.2014.29.2.256
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Squamous Cell Carcinoma of the Breast in a Patient with Crohn's Disease Taking Azathioprine
-
Park KC, Ju DU, Heo SW, Ryu JI, Cho JY, Kim EJ, Oh HK, Kim EY
- KMID: 1773074
- Korean J Gastroenterol.
- 2012 Dec;60(6):373-376.
- doi: 10.4166/kjg.2012.60.6.373
Azathioprine (AZA) treatment in transplant or autoimmune patients and subsequent appearance squamous cell carcinomas at various sites, particularly skin and cervix, has shown a close relationship. However, it remains uncertain... -
- CITED
-
- Close
- SHARE
-
- Close
- How Should Azathioprine Be Dosed in Crohn's Disease? A Novel Strategy of Maximum Dose-titration Based on the Lower Limit of Leukocyte Count and Tolerability
-
Lim CS, Moon W, Park SJ, Park MI, Choi JM, Yoo JH, Kim JB, Lee JS
- KMID: 1775748
- Korean J Gastroenterol.
- 2013 Aug;62(2):111-116.
- doi: 10.4166/kjg.2013.62.2.111
BACKGROUND/AIMS: Although general guidelines have suggested weight-based dosing of azathioprine (AZA, 2.5 mg/kg/day) for Crohn's disease (CD), a substantial number of patients develop bone marrow suppression. The aim of this... -
- CITED
-
- Close
- SHARE
-
- Close
